home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Libris Britannia 4
/
science library(b).zip
/
science library(b)
/
MEDICAL
/
1211.ZIP
/
49
< prev
next >
Wrap
Text File
|
1987-10-07
|
592b
|
16 lines
IN PATIENTS WITH RENAL IMPAIRMENT, TRIMETHOPRIM/SULFA DOSAGE
SHOULD BE CAREFULLY ADJUSTED TO AVOID TOXICITY (NEPHRO-
TOXICITY, ANTIFOLATE ACTION).
SOME CLINICIANS RECOMMEND THAT THE DOSAGE REGIMEN BE
ADJUSTED BASED ON THE PATIENT'S CREATININE CLEARANCE:
CREATININE DOSAGE INTERVAL
CLEARANCE METHOD
(ML/MINUTE)
10-50 18 hours
<10 24 hours